
Sandra L. Wegert
Examiner (ID: 8720)
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1647, 1646 |
| Total Applications | 523 |
| Issued Applications | 157 |
| Pending Applications | 99 |
| Abandoned Applications | 267 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7811443
[patent_doc_number] => 08133974
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-13
[patent_title] => 'Ferroportin1 nucleic acids, proteins, antibodies and methods'
[patent_app_type] => utility
[patent_app_number] => 12/381770
[patent_app_country] => US
[patent_app_date] => 2009-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 21144
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/133/08133974.pdf
[firstpage_image] =>[orig_patent_app_number] => 12381770
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/381770 | Ferroportin1 nucleic acids, proteins, antibodies and methods | Mar 15, 2009 | Issued |
Array
(
[id] => 5386531
[patent_doc_number] => 20090227776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR'
[patent_app_type] => utility
[patent_app_number] => 12/393224
[patent_app_country] => US
[patent_app_date] => 2009-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 56650
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20090227776.pdf
[firstpage_image] =>[orig_patent_app_number] => 12393224
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/393224 | COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR | Feb 25, 2009 | Abandoned |
Array
(
[id] => 5386533
[patent_doc_number] => 20090227778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'STABLE CELL LINES EXPRESSING HERG1A AND HERG1B'
[patent_app_type] => utility
[patent_app_number] => 12/388384
[patent_app_country] => US
[patent_app_date] => 2009-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6952
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20090227778.pdf
[firstpage_image] =>[orig_patent_app_number] => 12388384
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/388384 | Stable cell lines expressing HERG1a and HERG1b | Feb 17, 2009 | Issued |
Array
(
[id] => 5502190
[patent_doc_number] => 20090162878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => 'METHODS AND COMPOSITIONS FOR DETECTING AND QUANTIFYING SAPPB'
[patent_app_type] => utility
[patent_app_number] => 12/353162
[patent_app_country] => US
[patent_app_date] => 2009-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 10978
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20090162878.pdf
[firstpage_image] =>[orig_patent_app_number] => 12353162
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/353162 | METHODS AND COMPOSITIONS FOR DETECTING AND QUANTIFYING SAPPB | Jan 12, 2009 | Abandoned |
Array
(
[id] => 5479609
[patent_doc_number] => 20090202566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'Use of the ENDO-180 gene and polypeptide for diagnosis and treatment'
[patent_app_type] => utility
[patent_app_number] => 12/317231
[patent_app_country] => US
[patent_app_date] => 2008-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13382
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20090202566.pdf
[firstpage_image] =>[orig_patent_app_number] => 12317231
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/317231 | Use of the ENDO-180 gene and polypeptide for diagnosis and treatment | Dec 18, 2008 | Abandoned |
Array
(
[id] => 5515384
[patent_doc_number] => 20090215691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'NOGO Receptor Antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/335328
[patent_app_country] => US
[patent_app_date] => 2008-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 23683
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20090215691.pdf
[firstpage_image] =>[orig_patent_app_number] => 12335328
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/335328 | Nogo receptor antagonists | Dec 14, 2008 | Issued |
Array
(
[id] => 6534863
[patent_doc_number] => 20100204115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'USE OF ACETYL- (ALA10, 11)-RANTES (1-14) AND/OR CALCITONIN AS ANTI-ANGIOGENIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/677544
[patent_app_country] => US
[patent_app_date] => 2008-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35824
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20100204115.pdf
[firstpage_image] =>[orig_patent_app_number] => 12677544
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677544 | USE OF ACETYL- (ALA10, 11)-RANTES (1-14) AND/OR CALCITONIN AS ANTI-ANGIOGENIC AGENTS | Sep 8, 2008 | Abandoned |
Array
(
[id] => 6326940
[patent_doc_number] => 20100197603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'USE OF RGDSPASSKP AND OPTIONALLY ANGIOTENSIN II AS THERAPEUTIC AGENTS IN THE TREATMENT OF EG S. PNEUMONIAE INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 12/676927
[patent_app_country] => US
[patent_app_date] => 2008-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36020
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20100197603.pdf
[firstpage_image] =>[orig_patent_app_number] => 12676927
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/676927 | USE OF RGDSPASSKP AND OPTIONALLY ANGIOTENSIN II AS THERAPEUTIC AGENTS IN THE TREATMENT OF EG S. PNEUMONIAE INFECTIONS | Sep 8, 2008 | Abandoned |
Array
(
[id] => 6534780
[patent_doc_number] => 20100204110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'USE OF A PEPTIDE AS A THERAPEUTIC AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/677390
[patent_app_country] => US
[patent_app_date] => 2008-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35693
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20100204110.pdf
[firstpage_image] =>[orig_patent_app_number] => 12677390
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677390 | USE OF A PEPTIDE AS A THERAPEUTIC AGENT | Sep 8, 2008 | Abandoned |
Array
(
[id] => 6518679
[patent_doc_number] => 20100216976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'Sodium-independent transporter carrying acidic amino acid and its gene'
[patent_app_type] => utility
[patent_app_number] => 12/228769
[patent_app_country] => US
[patent_app_date] => 2008-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 9632
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20100216976.pdf
[firstpage_image] =>[orig_patent_app_number] => 12228769
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/228769 | Sodium-independent transporter carrying acidic amino acid and its gene | Aug 14, 2008 | Abandoned |
Array
(
[id] => 8577902
[patent_doc_number] => 08344112
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-01
[patent_title] => 'IGF-1R specific antibodies useful in the detection and diagnosis of cellular proliferative disorders'
[patent_app_type] => utility
[patent_app_number] => 12/670863
[patent_app_country] => US
[patent_app_date] => 2008-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 20
[patent_no_of_words] => 50634
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12670863
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/670863 | IGF-1R specific antibodies useful in the detection and diagnosis of cellular proliferative disorders | Jul 24, 2008 | Issued |
Array
(
[id] => 5563721
[patent_doc_number] => 20090136573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'Methods for Making and Delivering Rho-Antagonist Tissue Adhesive Formulations to the Injured Mammalian Central and Peripheral Nervous Systems and uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/175268
[patent_app_country] => US
[patent_app_date] => 2008-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15720
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20090136573.pdf
[firstpage_image] =>[orig_patent_app_number] => 12175268
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/175268 | Methods for Making and Delivering Rho-Antagonist Tissue Adhesive Formulations to the Injured Mammalian Central and Peripheral Nervous Systems and uses Thereof | Jul 16, 2008 | Abandoned |
Array
(
[id] => 8017627
[patent_doc_number] => 08138317
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-20
[patent_title] => 'Purification of pegylated polypeptides'
[patent_app_type] => utility
[patent_app_number] => 12/218545
[patent_app_country] => US
[patent_app_date] => 2008-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8376
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 240
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/138/08138317.pdf
[firstpage_image] =>[orig_patent_app_number] => 12218545
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/218545 | Purification of pegylated polypeptides | Jul 15, 2008 | Issued |
Array
(
[id] => 6270716
[patent_doc_number] => 20100254983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'USES OF RAGE ANTAGONISTS FOR TREATING OBESITY AND RELATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/451894
[patent_app_country] => US
[patent_app_date] => 2008-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12900
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20100254983.pdf
[firstpage_image] =>[orig_patent_app_number] => 12451894
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/451894 | USES OF RAGE ANTAGONISTS FOR TREATING OBESITY AND RELATED DISEASES | Jun 5, 2008 | Abandoned |
Array
(
[id] => 5507990
[patent_doc_number] => 20090081197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'Methods for Selection of Melanocortin Receptor-Specific Agents for Treatment of Obesity'
[patent_app_type] => utility
[patent_app_number] => 12/130299
[patent_app_country] => US
[patent_app_date] => 2008-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25762
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081197.pdf
[firstpage_image] =>[orig_patent_app_number] => 12130299
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/130299 | Methods for Selection of Melanocortin Receptor-Specific Agents for Treatment of Obesity | May 29, 2008 | Abandoned |
Array
(
[id] => 5295950
[patent_doc_number] => 20090010876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'VISFATIN AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/123988
[patent_app_country] => US
[patent_app_date] => 2008-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 27419
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20090010876.pdf
[firstpage_image] =>[orig_patent_app_number] => 12123988
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/123988 | VISFATIN AND USES THEREOF | May 19, 2008 | Abandoned |
Array
(
[id] => 5585468
[patent_doc_number] => 20090104670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'N-carbobenzyloxy (N-CBZ)-deprotecting enzyme and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 12/150544
[patent_app_country] => US
[patent_app_date] => 2008-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20433
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20090104670.pdf
[firstpage_image] =>[orig_patent_app_number] => 12150544
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/150544 | N-carbobenzyloxy (N-CBZ)-deprotecting enzyme and uses therefor | Apr 27, 2008 | Issued |
Array
(
[id] => 4792189
[patent_doc_number] => 20080293163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'Methods to identify compounds that modulate rage'
[patent_app_type] => utility
[patent_app_number] => 12/080948
[patent_app_country] => US
[patent_app_date] => 2008-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 9905
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20080293163.pdf
[firstpage_image] =>[orig_patent_app_number] => 12080948
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/080948 | Methods to identify compounds that modulate rage | Apr 6, 2008 | Abandoned |
Array
(
[id] => 5527201
[patent_doc_number] => 20090197278
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2009-08-06
[patent_title] => 'Antibodies to hADA2'
[patent_app_type] => utility
[patent_app_number] => 12/036846
[patent_app_country] => US
[patent_app_date] => 2008-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 14548
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0197/20090197278.pdf
[firstpage_image] =>[orig_patent_app_number] => 12036846
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/036846 | Antibodies to hADA2 | Feb 24, 2008 | Abandoned |
Array
(
[id] => 5527201
[patent_doc_number] => 20090197278
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2009-08-06
[patent_title] => 'Antibodies to hADA2'
[patent_app_type] => utility
[patent_app_number] => 12/036846
[patent_app_country] => US
[patent_app_date] => 2008-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 14548
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0197/20090197278.pdf
[firstpage_image] =>[orig_patent_app_number] => 12036846
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/036846 | Human Genes, Sequences and Expression Products | Feb 24, 2008 | Abandoned |